UNSPSC 51263146: Arotinolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H21N3O2S3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9DOI1HT306, chemically known as 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, monohydrochloride, (+-)- but more generally known as arotinolol hydrochloride, which bears US NIH Compound Identifier 155032.

European Medicines Agency schedules Arotinolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00590MIG. Most nations, for tariff and trade purposes, schedule arotinolol hydrochloride under HS 29341000 and SITC 51579. As of Q4 2014, AROTINOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)(C)NCC(CSC1NC(CS1)C2CCC(S2)C(=O)N)O.CL.

UNSPSC 51263146 Arotinolol hydrochloride is a Commodity code that covers pharmaceutical products, though the recent state and local procurement activity tagged to this code does not align with its nominal scope — the posted opportunity involves naloxone and drug deactivation systems rather than arotinolol, a beta-blocking antihypertensive agent. The code shows minimal relevant recent activity; procurement under this specific commodity designation appears limited or dormant in the state and local market.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, and vendors were required to include shipping and delivery costs in their bids, maintain standard workplace certifications and insurance coverage, and comply with E-Verify requirements. The contract structure included a two-year initial term with an optional one-year renewal and a three-month probationary period. This single recent posting does not establish a pattern of state or local demand for arotinolol hydrochloride specifically; the code's applicability to state and local health and human services procurement remains unclear based on available opportunities.